Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Total article views   HTML views PDF downloads Totals
11,820 Dovepress* 10,850+ 1,503 12,353
PubMed Central* 970 363 1,333
Totals 11,820 1,866 13,686
*Since 27 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 1 0 0 4 5

View citations on PubMed Central and Google Scholar